AU2006259663A1 - Tubulin inhibitor and process for its preparation - Google Patents

Tubulin inhibitor and process for its preparation Download PDF

Info

Publication number
AU2006259663A1
AU2006259663A1 AU2006259663A AU2006259663A AU2006259663A1 AU 2006259663 A1 AU2006259663 A1 AU 2006259663A1 AU 2006259663 A AU2006259663 A AU 2006259663A AU 2006259663 A AU2006259663 A AU 2006259663A AU 2006259663 A1 AU2006259663 A1 AU 2006259663A1
Authority
AU
Australia
Prior art keywords
trifluoro
pyrazin
process according
phenyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006259663A
Other languages
English (en)
Inventor
Jay Thomas Afragola
David Michael Blum
Timothy John Doyle
Jean Schmid
Yanzhong Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37074929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2006259663(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of AU2006259663A1 publication Critical patent/AU2006259663A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2006259663A 2005-06-13 2006-06-08 Tubulin inhibitor and process for its preparation Abandoned AU2006259663A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69001605P 2005-06-13 2005-06-13
US60/690,016 2005-06-13
US80278106P 2006-05-24 2006-05-24
US60/802,781 2006-05-24
PCT/US2006/022574 WO2006138180A1 (fr) 2005-06-13 2006-06-08 Inhibiteur de tubuline et sa methode de preparation

Publications (1)

Publication Number Publication Date
AU2006259663A1 true AU2006259663A1 (en) 2006-12-28

Family

ID=37074929

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006259663A Abandoned AU2006259663A1 (en) 2005-06-13 2006-06-08 Tubulin inhibitor and process for its preparation

Country Status (12)

Country Link
EP (1) EP1891052A1 (fr)
JP (1) JP2008543838A (fr)
AR (1) AR054392A1 (fr)
AU (1) AU2006259663A1 (fr)
BR (1) BRPI0612145A2 (fr)
CA (1) CA2610416A1 (fr)
GT (1) GT200600257A (fr)
MX (1) MX2007015718A (fr)
PE (1) PE20070114A1 (fr)
SV (1) SV2007002573A (fr)
TW (1) TW200716613A (fr)
WO (1) WO2006138180A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2581207T3 (es) 2009-11-12 2016-09-02 Tube Pharmaceuticals Gmbh Inhibidores de la tubulina
EP2903436B1 (fr) * 2012-09-19 2019-07-17 The Trustees Of The University Of Pennsylvania Composés hétérocycliques et leur utilisation pour le traitement de tauopathies neurodégénératives
WO2017181974A1 (fr) * 2016-04-20 2017-10-26 苏州苏领生物医药有限公司 Composé hétérocyclique à cinq chaînons, procédé de préparation correspondant, composition pharmaceutique et utilisation
WO2019169111A1 (fr) 2018-03-02 2019-09-06 The Trustees Of The University Of Pennsylvania Composés de [1,2,4]triazolo[1,5-a]pyrimidine et utilisation de ces derniers dans la stabilisation de microtubules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003207A (es) * 2003-09-24 2006-06-23 Wyeth Corp 5-arilpirimidinas como agentes anti-cancer.
CN100519559C (zh) * 2003-09-24 2009-07-29 惠氏控股公司 作为抗癌剂的6-[(经取代的)苯基]三唑并嘧啶

Also Published As

Publication number Publication date
SV2007002573A (es) 2007-01-03
PE20070114A1 (es) 2007-02-03
BRPI0612145A2 (pt) 2010-10-19
TW200716613A (en) 2007-05-01
EP1891052A1 (fr) 2008-02-27
JP2008543838A (ja) 2008-12-04
GT200600257A (es) 2007-02-14
AR054392A1 (es) 2007-06-20
MX2007015718A (es) 2008-02-21
CA2610416A1 (fr) 2006-12-28
WO2006138180A1 (fr) 2006-12-28

Similar Documents

Publication Publication Date Title
KR101612642B1 (ko) 테노포비어 알라펜아미드 헤미푸마레이트
EP0303697A1 (fr) Derives de la substance physiologiquement active k-252
EP3173412B1 (fr) Dérivé 7h-pyrrolo[2,3-d]pyrimidine 2,4-disubstituté, procédé de préparation et utilisation médicinale de ce dernier
JP2018021072A (ja) 治療活性化合物およびそれらの使用方法
US10287254B2 (en) Salts of a dihydroquinazoline derivative
US20230250087A1 (en) Solid forms of apol1 inhibitor and methods of using same
CN104024229A (zh) 三唑并嘧啶化合物的合成
JP2023512213A (ja) Ａｐｏｌ１の阻害剤およびこれを使用する方法
CN115141215A (zh) Kras g12d蛋白抑制剂和其用途
US8541419B2 (en) Isotopically enriched pyrimidin-5-yl acetic acid derivatives as CRTH2 antagonists
EP2889287B1 (fr) Dérivé de dolastatine-10, procédé pour le produire et composition de médicament anticancéreux le contenant
EA025863B1 (ru) Карбазолкарбоксамидные соединения
AU2006259663A1 (en) Tubulin inhibitor and process for its preparation
KR20060089215A (ko) 항암제로서의 5-아릴피리미딘
KR20060098368A (ko) 항암제로서의 6-[(치환된)페닐]트리아졸로피리미딘
US7501423B2 (en) Tubulin inhibitor and process for its preparation
RU2656485C2 (ru) Дейтерированные соединения хиназолинона и содержащие их фармацевтические композиции
US7396835B2 (en) Process for the preparation of tubulin inhibitors
EP4324835A1 (fr) Dérivé de pyrimidinone et son procédé de préparation, composition pharmaceutique et utilisation
CN113557236B (zh) 一种双功能免疫调节剂及其在药学上可接受的盐、药物组合物
US20190315767A1 (en) Tricyclic ask1 inhibitors
JPH07242670A (ja) ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体及びこれを含有する循環器系疾患治療剤
WO2024054624A1 (fr) Modulateurs d'alpha-1 antitrypsine
WO2024088189A1 (fr) Composé macrocyclique utilisé en tant qu'inhibiteur de cdk9 et son utilisation
JP2023531992A (ja) アミノピリミジニル誘導体

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period